(R)-Tegoprazan
Modify Date: 2024-04-06 13:17:21
(R)-Tegoprazan structure
|
Common Name | (R)-Tegoprazan | ||
|---|---|---|---|---|
| CAS Number | 942195-56-4 | Molecular Weight | 387.38 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H19F2N3O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (R)-Tegoprazan(R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H+/K+-ATPase inhibitor with an IC50 of 98 nM of canine kidney Na+/K+-ATPase. (R)-Tegoprazan has the potential for gastrointestinal diseases research[1]. |
| Name | (R)-Tegoprazan |
|---|
| Description | (R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H+/K+-ATPase inhibitor with an IC50 of 98 nM of canine kidney Na+/K+-ATPase. (R)-Tegoprazan has the potential for gastrointestinal diseases research[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Takeshi Hanazawa, et al. Chromane Substituted Benzimidazole Derivatives. US20070142448A1. |
| Molecular Formula | C20H19F2N3O3 |
|---|---|
| Molecular Weight | 387.38 |